S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
The gold catalyst we’ve waited for (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Biden To Unleash "Choke Point" Operation On America? (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
The gold catalyst we’ve waited for (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Biden To Unleash "Choke Point" Operation On America? (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
The gold catalyst we’ve waited for (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Biden To Unleash "Choke Point" Operation On America? (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
The gold catalyst we’ve waited for (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Biden To Unleash "Choke Point" Operation On America? (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
NASDAQ:NXGN

NextGen Healthcare - NXGN Stock Forecast, Price & News

$17.32
0.00 (0.00%)
(As of 03/29/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.23
$17.48
50-Day Range
$16.69
$19.31
52-Week Range
$16.13
$21.99
Volume
208,883 shs
Average Volume
458,396 shs
Market Capitalization
$1.14 billion
P/E Ratio
49.49
Dividend Yield
N/A
Price Target
$22.75

NextGen Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
31.4% Upside
$22.75 Price Target
Short Interest
Bearish
6.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of NextGen Healthcare in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.37%
From $0.54 to $0.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

230th out of 999 stocks

Computer Integrated Systems Design Industry

10th out of 36 stocks


NXGN stock logo

About NextGen Healthcare (NASDAQ:NXGN) Stock

NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.

Receive NXGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NXGN Stock News Headlines

My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
NextGen Healthcare Announces Mirth Cloud Connect
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
NextGen Healthcare, Inc. (NXGN)
NXGN.O
NextGen Healthcare Earnings Preview
Nextgen Healthcare
See More Headlines
Receive NXGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NXGN Company Calendar

Last Earnings
1/24/2023
Today
3/29/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
5/16/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NXGN
Employees
2,655
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$22.75
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+31.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$1.62 million
Pretax Margin
5.01%

Debt

Sales & Book Value

Annual Sales
$625.88 million
Cash Flow
$1.34 per share
Book Value
$6.33 per share

Miscellaneous

Free Float
63,051,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
1.03

Key Executives

  • David William SidesDavid William Sides
    President, Chief Executive Officer & Director
  • L. Allen Plunk
    Executive Vice President-Operations
  • James R. Arnold
    Chief Financial Officer & Executive Vice President
  • Robert L. Murry
    Chief Medical Officer
  • David Slazyk
    Chief Information & Security Officer













NXGN Stock - Frequently Asked Questions

Should I buy or sell NextGen Healthcare stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NXGN shares.
View NXGN analyst ratings
or view top-rated stocks.

What is NextGen Healthcare's stock price forecast for 2023?

4 Wall Street analysts have issued 12-month price targets for NextGen Healthcare's shares. Their NXGN share price forecasts range from $20.00 to $26.00. On average, they anticipate the company's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 31.3% from the stock's current price.
View analysts price targets for NXGN
or view top-rated stocks among Wall Street analysts.

How have NXGN shares performed in 2023?

NextGen Healthcare's stock was trading at $18.78 at the beginning of 2023. Since then, NXGN stock has decreased by 7.7% and is now trading at $17.33.
View the best growth stocks for 2023 here
.

When is NextGen Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 16th 2023.
View our NXGN earnings forecast
.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its quarterly earnings results on Tuesday, January, 24th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.17 by $0.04. The company earned $161.88 million during the quarter, compared to analyst estimates of $160.15 million. NextGen Healthcare had a net margin of 3.66% and a trailing twelve-month return on equity of 6.46%.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare updated its FY23 earnings guidance on Tuesday, January, 24th. The company provided earnings per share (EPS) guidance of $0.93-0.99 for the period, compared to the consensus EPS estimate of $0.97. The company issued revenue guidance of $642-650 million, compared to the consensus revenue estimate of $639.63 million.

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.44%), William Blair Investment Management LLC (2.33%), Millennium Management LLC (2.25%), Geode Capital Management LLC (1.65%), Assenagon Asset Management S.A. (1.28%) and Lazard Asset Management LLC (1.15%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends
.

How do I buy shares of NextGen Healthcare?

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $17.33.

How much money does NextGen Healthcare make?

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.14 billion and generates $625.88 million in revenue each year. The company earns $1.62 million in net income (profit) each year or $0.35 on an earnings per share basis.

How many employees does NextGen Healthcare have?

The company employs 2,655 workers across the globe.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (949) 255-2600, via email at ir@nextgen.com, or via fax at 949-255-2605.

This page (NASDAQ:NXGN) was last updated on 3/30/2023 by MarketBeat.com Staff